Literature DB >> 11606684

The range of multiple sclerosis associated with neurofibromatosis type 1.

P Perini1, P Gallo.   

Abstract

Multiple sclerosis associated with neurofibromatosis type 1 (NF1) is a very rare event. Seven patients with multiple sclerosis and NF1 are described in the literature, and all were reported to have the primary progressive form of multiple sclerosis. Three new patients with NF1 that developed multiple sclerosis are described and it is shown that the range of multiple sclerosis associated with NF1 includes the relapsing forms of the disease. The risk of having both NF1 and multiple sclerosis in north east Italy is higher than would be expected based on the prevalence rates of the two diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606684      PMCID: PMC1737605          DOI: 10.1136/jnnp.71.5.679

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

1.  A case of neurofibromatosis and multiple sclerosis.

Authors:  Gabriella Spinicci; Maria Valeria Cherchi; Raffaele Murru; Maria Conti; Maria Giovanna Marrosu
Journal:  Neurol Sci       Date:  2010-04-28       Impact factor: 3.307

2.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

3.  Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS).

Authors:  Silvia Ciotti; Antonella Cometa; Claudia De Carlo; Giancarlo Martini; Andrea Marona; Laura Filippetti; Diego Carducci; Silvano Baratta; Mauro Zampolini; Francesco Corea
Journal:  Eur J Case Rep Intern Med       Date:  2021-02-03

Review 4.  The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.

Authors:  Peter O Behan; Abhijit Chaudhuri
Journal:  Inflammopharmacology       Date:  2010-09-24       Impact factor: 5.093

5.  Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.

Authors:  Nafiseh Mohebi; Mehdi Moghaddasi; Zaribafian Maryam
Journal:  Neurol Int       Date:  2015-09-24

6.  Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.

Authors:  Chinwe C Madubata; Margaret A Olsen; Dustin L Stwalley; David H Gutmann; Kimberly J Johnson
Journal:  Genet Med       Date:  2014-06-05       Impact factor: 8.822

7.  Neurofibromatosis I and multiple sclerosis.

Authors:  Christina Bergqvist; François Hemery; Salah Ferkal; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-07-14       Impact factor: 4.123

8.  Primary Progressive Multiple Sclerosis in a Portuguese Patient With Neurofibromatosis Type 1.

Authors:  Inês Carvalho; Miguel Quintas-Neves; Joana Pinto; Ana Filipa Santos; João Pereira
Journal:  Cureus       Date:  2021-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.